Ocean Biomedical, Inc.
OCEA· OTC
OCEAOcean Biomedical, Inc.
Quarterly figures for Ocean Biomedical, Inc., with source filings when available.
14 quarters. Sep 30, 2021 to Mar 31, 2025. mixed units.
Ocean Biomedical, Inc. has filed its 10-Q within 11 to 176 days of period end across its last 8 quarters. The 10-K runs 31 to 98 days.
Ocean Biomedical, Inc. · CIK 1869974 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | |||||||||
| Q1 2025 | Mar 31, 2025 | — | May 15, 2025 | 45 d | 10-Q | — | — | -$0.09 | |
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | Apr 8, 2025 | 98 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | — | Jan 13, 2025 | 105 d | 10-Q | — | — | -$0.13 | |
| Q2 2024 | Jun 30, 2024 | — | Dec 23, 2024 | 176 d | 10-Q | — | — | -$0.63 | |
| Q1 2024 | Mar 31, 2024 | — | Dec 23, 2024 | 267 d | 10-Q | — | — | $0.48 | |
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Nov 25, 2024 | 330 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Apr 15, 2024 | 198 d | 10-Q | ||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 31, 2023 | 90 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Oct 17, 2022 | 17 d | 10-Q | ||||
| FY 2021 | |||||||||
| Q3 2021 | Sep 30, 2021 | — | Oct 18, 2021 | 18 d | 10-Q | — | — | -$0.02 | |
| — |
| — |
| -$0.53 |
| Q2 2023 | Jun 30, 2023 | — | Aug 14, 2023 | 45 d | 10-Q | — | — | -$0.43 |
|---|
| Q1 2023 | Mar 31, 2023 | — | May 24, 2023 | 54 d | 10-Q | — | — | -$2.90 |
|---|
| — |
| — |
| -$0.16 |
| Q2 2022 | Jun 30, 2022 | — | Jul 11, 2022 | 11 d | 10-Q | — | — | -$0.31 |
|---|
| Q1 2022 | Mar 31, 2022 | — | Apr 25, 2022 | 25 d | 10-Q | — | — | -$0.23 |
|---|
